NGFR and Alzheimer disease: To further investigate whether serum p75NTR-ECD could be used as a predictor of AD progression, we divided AD patients into three subsets according to the MMSE score: MMSE⩽10, MMSE=11–20 and MMSE⩾21, and compared the difference in the p75NTR-ECD level between these three subsets.